Health Care & Life Sciences » Biotechnology | Anhui Anke Biotechnology

Anhui Anke Biotechnology | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
425
538
632
840
1,082
1,446
Cost of Goods Sold (COGS) incl. D&A
121
162
190
238
267
323
Gross Income
304
377
442
602
815
1,123
SG&A Expense
205
253
289
382
513
800
EBIT
96
125
156
228
302
322
Unusual Expense
-
3
1
-
-
5
Non Operating Income/Expense
1
4
6
14
33
7
Interest Expense
-
-
-
3
2
3
Pretax Income
106
127
156
232
335
319
Income Tax
16
18
24
33
47
45
Equity in Affiliates
-
-
-
1
5
10
Consolidated Net Income
90
109
132
198
282
265
Net Income
90
110
136
197
278
263
Net Income After Extraordinaries
90
110
136
197
278
263
Net Income Available to Common
90
110
136
197
278
263
EPS (Basic)
0.10
0.12
0.15
0.20
0.28
0.26
Basic Shares Outstanding
883
893
895
971
997
997
EPS (Diluted)
0.10
0.12
0.15
0.20
0.28
0.26
Diluted Shares Outstanding
883
893
895
971
997
997
EBITDA
112
149
184
274
358
381
Other Operating Expense
3
1
3
8
-
-
Non-Operating Interest Income
5
6
3
3
2
3
Minority Interest Expense
-
1
4
1
4
2

About Anhui Anke Biotechnology

View Profile
Address
K-1, Haiguan Road
Hefei Anhui 230088
China
Employees -
Website http://www.ankebio.com
Updated 07/08/2019
Anhui Anke Biotechnology (Group) Co., Ltd. engages in the research and development, manufacture, and sale of biopharmaceutical products. Its business activities include implementation of precision medical development strategy, formation of genetic testing, and development of anti-tumor drugs and cell immunotherapy technology. Its products consist of biological products, modern Chinese medicine, chemical synthetic drugs, peptide active pharmaceutical ingredients, nucleic acid detection, and cosmetic products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.